Real-world comparative effectiveness of a third dose of mRNA-1273 versus BNT162b2 among adults aged ≥ 65 years in the United States-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-world comparative effectiveness of a third dose of mRNA-1273 versus BNT162b2 among adults aged ≥ 65 years in the United States

Published:2024-11 Issue:25 Volume:42 Page:126113
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Kirk Brenna^ORCID,Bush Christopher^ORCID,Toyip Astra,Mues Katherine E.,Beck Ekkehard,Li Linwei,St. Laurent Samantha,Georgieva Mihaela,Marks Morgan A.,Sun Tianyu,Esposito Daina B.,Martin David,Van de Velde Nicolas

Publisher

Elsevier BV

Reference28 articles.

1. United States of America: WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data. Accessed October 18, 2022. https://covid19.who.int.

2. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study;Watson;Lancet Infect Dis,2022

3. US Food and Drug Administration. Pfizer-BioNTech COVID-19 Vaccine. Published online May 19, 2021. Accessed May 20, 2021. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine.

4. Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine;Patalon;Nat Commun,2022

5. Safety and efficacy of a third dose of BNT162b2 Covid-19 vaccine;Moreira;N Engl J Med,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP